About us

The Company profits from the in-house, tightly-teamed expertises of national and international basic and clinical scientists, and business people, that upon need can also take advantage of a panel of highly-acknowledged international scientific consultants.

more info: info@epigentherapeutics.com

Team

Sandra Coral

Chief Science Officer (CSO)

PhD, has more than 20 years of international experience and published over 40 studies in epigenetics, cancer immunology and immunotherapy.

Giorgio Costacurta

Development & Marketing

Entrepreneur, Business Advisor, Angel Investor, Mentor, Executive Director from over 30 years.

TBD

Managing Director

Maria F. Lofiego

Research Scientist

M.Sc, PhD student, has 2 years of experience in epigenetics and cancer immunology.

Alessia Covre

External Collaborator

PhD, has more than 10 years of international experience and co – authored 20 scientific papers in microbiology,  epigenetics, cancer immunology and immunotherapy.

Patrizia Tunici

External Collaborator

PhD, Specialist in In vivo studies with experimental animals. 2008-2014 Principal Scientist at Siena Biotech, S.p.a, Pharm. Dept.

Carolina Fazio

Research Scientist

PhD, has 5 years of experience in molecular assays for epigenetics and cancer immunotherapy studies.

scientific advisory board

Roberto Camerini

MD

Pre-Clinical and Clinical Research & Development Director, Alfa Wassermann S.p.A., Bologna, Italy.

Pier Giorgio Natali

MD PhD

Former Scietific Director of the Regina Elena Cancer Istitute, Rome, Italy.

Hugues JMG Nicolay

PhD MBA

Laboratory and Building Mananger, Ludwig Center for Cancer Research of the University of Lausanne (LICR@UNIL) Switzerland.

Scientific Consultant

Michele Maio

MD PhD

Specialist in cancer immunotherapy
Director of  Center for Immuno-Oncology
Head of Medical Oncology and Immunotherapy, University Hospital of Siena, Italy
Fondazione NIBIT President.